Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020).

Leonetti A, Pluchino M, Minari R, Passiglia F, Pizzutilo EG, Cortinovis DL, Toschi L, Gelsomino F, Frega S, Metro G, Belluomini L, Montrone M, Camerini A, Bertolini A, Baldini E, Mazzoni F, Bria E, Bertolini F, Del Conte A, Bordi P, Perrone F, Verzè M, D'Agnelli S, Onorini P, Cosenza A, Facchinetti F, Boni L, Tognetto M, Tiseo M

Open source

DOI: 10.1200/po-25-01107
Published: 2026 Jun
Container: JCO precision oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/po-25-01107,
  title = {Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020).},
  author = {Leonetti A and Pluchino M and Minari R and Passiglia F and Pizzutilo EG and Cortinovis DL and Toschi L and Gelsomino F and Frega S and Metro G and Belluomini L and Montrone M and Camerini A and Bertolini A and Baldini E and Mazzoni F and Bria E and Bertolini F and Del Conte A and Bordi P and Perrone F and Verzè M and D'Agnelli S and Onorini P and Cosenza A and Facchinetti F and Boni L and Tognetto M and Tiseo M},
  year = {2026},
  journal = {JCO precision oncology},
  doi = {10.1200/po-25-01107},
  url = {https://doi.org/10.1200/po-25-01107}
}

RIS

TY  - JOUR
TI  - Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020).
AU  - Leonetti A
AU  - Pluchino M
AU  - Minari R
AU  - Passiglia F
AU  - Pizzutilo EG
AU  - Cortinovis DL
AU  - Toschi L
AU  - Gelsomino F
AU  - Frega S
AU  - Metro G
AU  - Belluomini L
AU  - Montrone M
AU  - Camerini A
AU  - Bertolini A
AU  - Baldini E
AU  - Mazzoni F
AU  - Bria E
AU  - Bertolini F
AU  - Del Conte A
AU  - Bordi P
AU  - Perrone F
AU  - Verzè M
AU  - D'Agnelli S
AU  - Onorini P
AU  - Cosenza A
AU  - Facchinetti F
AU  - Boni L
AU  - Tognetto M
AU  - Tiseo M
PY  - 2026
JO  - JCO precision oncology
DO  - 10.1200/po-25-01107
UR  - https://doi.org/10.1200/po-25-01107
ER  -

APA

A, L., M, P., R, M., F, P., EG, P., DL, C., L, T., F, G., S, F., G, M., L, B., M, M., A, C., A, B., E, B., F, M., E, B., F, B., A, D. C., P, B., F, P., M, V., S, D., P, O., A, C., F, F., L, B., M, T., & M, T. (2026). Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020).. JCO precision oncology. https://doi.org/10.1200/po-25-01107

Source records

pubmed · retrieved 2026-09-26T15:23:10.822Z